Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with …

JA Bonner, PM Harari, J Giralt, N Azarnia… - Journal of Clinical …, 2004 - ascopubs.org
5507 Background: The majority of head and neck cancers overexpress the epidermal
growth factor receptor (EGFR), which is associated with aggressive tumor behavior and poor …
被引用次数：205 相关文章

[引用][C] Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation …

JA Bonner, PM Harari, J Giralt, N Azarnia… - Journal of Clinical …, 2004 - cir.nii.ac.jp
Cetuximab prolongs survival in patients with locoregionally advanced squamous cell
carcinoma of head and neck: A phase III study of high dose radiation therapy with or without …

[引用][C] Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation …

JA BONNER - J. Clin. Oncol., 2004 ASCO Annual Meeting …, 2004 - cir.nii.ac.jp
Cetuximab prolongs survival in patients with locoregionally advanced squamous cell
carcinoma of head and neck : A phase III study of high dose radiation therapy with or without …